Primary study · included by 1 review

Randomized controlled trial of the effect of periodontal treatment on cardiovascular risk biomarkers in patients with stable coronary artery disease: Preliminary findings of 3 months

Montenegro 2019 · Montenegro Marlon M., Ribeiro Ingrid W. J., Kampits Cassio, et al. · Journal of Clinical Periodontology · 2019

Included by

Decoding the periodontitis-coronary artery disease axis through biomarker profiling: a systematic review and meta-analysis.
Non-Cochrane · aetiology · 2026 · cited as Montenegro 2019 · Table 1; Fig. 3 and Fig. 5
Outcome this study informsPooled effectEvidenceCertainty
Interleukin-6 level
Periodontitis with CAD or cardiovascular risk indicators (exposure) vs Controls without periodontitis and/or without CAD or cardiovascular risk indicators · Baseline
SMD 0.166 [-0.111, 0.443]3 studiesGRADE not reported
C-reactive protein level
Periodontitis with CAD or cardiovascular risk indicators (exposure) vs Controls without periodontitis and/or without CAD or cardiovascular risk indicators · Baseline
SMD 0.573 [0.065, 1.082]5 studiesGRADE not reported
C-reactive protein level
Periodontitis with CAD or cardiovascular risk indicators (exposure) vs Controls without periodontitis and/or without CAD or cardiovascular risk indicators · Baseline
SMD 0.39305 studiesGRADE not reported
C-reactive protein level
Periodontitis with CAD or cardiovascular risk indicators (exposure) vs Controls without periodontitis and/or without CAD or cardiovascular risk indicators · Baseline
SMD 0.501 [0.275, 0.728]5 studiesGRADE not reported
Interleukin-6 level
Periodontitis with CAD or cardiovascular risk indicators (exposure) vs Controls without periodontitis and/or without CAD or cardiovascular risk indicators · Baseline
SMD 0.1424 [-0.0769, 0.3616]3 studiesGRADE not reported
C-reactive protein level
Periodontitis with CAD or cardiovascular risk indicators (exposure) vs Controls without periodontitis and/or without CAD or cardiovascular risk indicators · Baseline
SMD 0.37085 studiesGRADE not reported
Interleukin-6 level
Periodontitis with CAD or cardiovascular risk indicators (exposure) vs Controls without periodontitis and/or without CAD or cardiovascular risk indicators · Baseline
SMD 0.166 [-0.111, 0.443]3 studiesGRADE not reported
Interleukin-6 level
Periodontitis with CAD or cardiovascular risk indicators (exposure) vs Controls without periodontitis and/or without CAD or cardiovascular risk indicators · Baseline
SMD 0.1424 [-0.0769, 0.3616]3 studiesGRADE not reported

1 including review in total.